Juan Carlos Hernández‐Boluda

ORCID: 0000-0002-4289-3113 · 2 papers in corpus

observational 2020

Clinico-biological characteristics of patients with myelofibrosis: an analysis of 1,000 cases from the Spanish Registry of Myelofibrosis

Medicina clinica ·doi:10.1016/j.medcle.2019.11.010

UNLABELLED: BACKGROUND AND OBJECTIVE MYELOFIBROSIS: is an infrequent chronic myeloproliferative neoplasm. We aimed to describe the clinico-biological characteristics, treatment, and evolutive course of myelofibrosis patients in Spain. MATE…

other 2000

Danazol treatment of idiopathic myelofibrosis with severe anemia

Haematologica

BACKGROUND AND OBJECTIVE: Severe anemia is an important problem in patients with idiopathic myelofibrosis (IM). When other therapeutic measures are unsuccessful or not applicable, 40-50% favorable responses are obtained with androgen therap…